维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Rathkopf"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase I pharmacokinetic and biodistribution study with escalating doses of 223 Ra-dichloride in men with castration-resistant metastatic prostate cancer显示文摘	Jorge A. Carrasquillo Joseph A. O’Donoghue Neeta Pandit-Taskar John L. Humm Dana E. Rathkopf Susan F. Slovin Matthew J. Williamson Kristine Lacuna Anne-Kirsti Aksnes Steven M. Larson Howard I. Scher Michael J. Morris	2013	European Journal of Nuclear Medicine and Molecular Imaging2013，，9：	1
2	Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium 显示文摘	BRADLEY D RATHKOPF D DUNN R	2009	Cancer2009，115，23：	1
3	Enzalutamide in metastatic prostate cancer before chemotherapy显示文摘	Beer TM Armstrong A J Rathkopf DE	2014	N Engl J Med2014，371，5：	1
4	A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol 显示文摘	Diekson MA Shah MA Rathkopf D	2010	Cancer Chemother Pharmacol2010，66，6：	1
5	Localization and Intrinsic Function显示文摘	Rathkopf C A	2013	Phi- losophy of Science2013，80，1：	1
6	Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiratcrone and enzalutamide显示文摘	Bambury RM Rathkopf DE	2016	Urol Oncol2016，34，8：	1
7	Enzalutamide in metastatic prostate cancer before chemotherapy 显示文摘	Beer TM Armstrong A J Rathkopf DE	2014	N Engl J Med2014，371，5：	1
8	Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer 显示文摘	Rathkopf DE Morris M J Fox JJ	2013	J Clin Oncol2013，31，28：	1
9	Androgen receptor antagonists in castration- resistant prostate cancer显示文摘	Rathkopf D Scher HI	2013	Cancer J2013，19，1：	1
10	A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors 显示文摘	Diekson MA Rathkopf DE Carvajal RD	2011	Invest New Drugs2011，29，5：	1
11	Updated interim ef-ficacy analysis and long-term safety of abiraterone acetate inmetastatic castration-resistant prostate cancer patients withoutprior chemotherapy (COU-AA-302) 显示文摘	Rathkopf D E Smith M R de Bono J S	2014	Eur Urol2014，66，5：	1
12	Enzalutamide inmetastatic prostate cancer before chemotherapy 显示文摘	Beer T M Armstrong A J5 Rathkopf D E5	2014	N Engl JMed2014，371，5：	1
13	Enzalutamide in metastatic prostate cancer before chemotherapy显示文摘	BEER TM ARMSTRONG AJ RATHKOPF DE	2014	N EnglJ Med2014，371，5：	1
14	Food allergy and eosinophilic gastrointestinal disorders:guiding our di- agnosis and treatment 显示文摘	Pratt ca adaemain JG Rathkopf mm	2008	Curt Probl Pediatr Adolesc Health Care2008，38，6：	1
15	A phase Ⅰ pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors 显示文摘	DICKSON M A RATHKOPF D E CARVAJAL R D	2011	Invest New Drugs2011，29，5：	1
16	Phase Ⅰ study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors 显示文摘	RATHKOPF D E DICKSON M A FELDMAN D R	2009	Clin Cancer Res2009，15，23：	1
17	Marked en- hancement of the immune response to BioThrax (R) ( Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers显示文摘	RYNKIEWICZ D RATHKOPF M SIM I	2011	Vaccine2011，29，37：	1
18	A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors显示文摘	Iyer G Morris MJ Rathkopf D	2012	Cancer Chemother Pharmacol2012，69，4：	1
19	Phase Ⅰ study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors显示文摘	Rathkopf D Dickson MA Feldman DR	2009	Clin Cancer Res2009，15，23：	1
20	Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors显示文摘	Rathkopf D Dickson MA Feldman DR	2009	Clinical Cancer Research2009，15，23：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示